Malaria Diagnostics Industry Overview
The global malaria diagnostics market size was valued at USD 728.8 million in 2021 and is anticipated to witness a CAGR of 5.4% during the forecast period. The rising demand for malaria diagnostics and the introduction of novel diagnostic techniques are the key factors driving the market. Malaria is one of the most widespread life-threatening diseases, commonly occurring in tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment. The tropical disease caused by the female Anopheles mosquito, infected by the Plasmodium species caused over 4,35,000 deaths globally in 2017, as stated by the World Health Organization (WHO). Statistics from the same source indicate that over 219 million cases of malaria were recorded globally, with over 92% of cases being reported from Africa, 6% from South East Asia, and 2% from the Eastern Mediterranean regions. Thus, rising disease incidence is also anticipated to boost the growth of the market for malaria diagnostics in the future.
In Africa, non-governmental and governmental organizations announced initiatives to support the COVID-19 research and control program. The Global Fund to Fight AIDS, Tuberculosis, and Malaria permitted receivers to use funds from already existing grants in order to control COVID-19. Efforts were taken to minimize and control the spread of the COVID-19 virus, to avoid situations that arose during the Ebola outbreak, where millions of Malaria cases were left untreated due to the severity of the Ebola virus. These were some of the factors driving the market for malaria diagnostics during the COVID-19 pandemic.
Gather more insights about the market drivers, restraints, and growth of the Global Malaria Diagnostics market
It is one of the leading causes of death in many African, Asian, and Latin American countries, such as Uganda, the Democratic Republic of Congo, Columbia, Peru, and India. Malaria during pregnancy can cause low birth weights, stillbirths, and congenital infection. Technological advancements are also expected to be one of the key drivers for the market for malaria diagnostics. Increasing demand and rising need for high-quality and cost-efficient diagnostic methods are likely to trigger advancements that can offer improved access to diagnostics, especially in remote areas. Heavy investments by government bodies and private investors to curb the disease prevalence is also one of the major factors driving the market for malaria diagnostics. According to the data published by WHO, in 2017, approximately USD 3.1 billion were invested in the control and elimination of the disease by private international investors and government authorities of endemic nations. Over 312 million rapid diagnostic tests were delivered globally, mostly in the WHO African region, which is the worst affected region.
Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.
Rapid Tests Market - The global rapid tests market size was valued at USD 1.29 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030.
Body Fluid Collection and Diagnostics Market - The global body fluid collection and diagnostics market size was valued at USD 30.19 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030.
Malaria Diagnostics Market Segmentation
Grand View Research has segmented the global malaria diagnostics market on the basis of technology and region:
Malaria Diagnostics Technology Outlook (Revenue, USD Million, 2017 - 2030)
- Microscopy
- Rapid Diagnostic Tests (RDTs)
- Molecular Diagnostic Tests
Malaria Diagnostics Regional Outlook (Revenue, USD Million, 2017 - 2030)
- Africa
- Southeast Asia
- Eastern Mediterranean
- Western Pacific
- America
- Europe
Key Companies profiled:
Some prominent players in the global Malaria Diagnostics market include:
- Access Bio., Inc.
- Abbott Laboratories
- Premier Medical Corporation Pvt. Ltd.
- Sysmex Partec GmbH
- bioMérieux
- Beckman Coulter, Inc.
- Siemens Healthineers
- Leica Microsystems GmbH
- Nikon Corporation
- Olympus Corporation
- Bio-Rad Laboratories, Inc.
Order a free sample PDF of the Malaria Diagnostics Market Intelligence Study, published by Grand View Research.
No comments:
Post a Comment